These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 27611239)
1. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency. Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239 [TBL] [Abstract][Full Text] [Related]
2. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells. Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421 [TBL] [Abstract][Full Text] [Related]
3. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency. Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323 [TBL] [Abstract][Full Text] [Related]
4. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency. Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813 [TBL] [Abstract][Full Text] [Related]
5. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642 [TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation. Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179 [TBL] [Abstract][Full Text] [Related]
8. Lentiviral Gene Therapy for Artemis-Deficient SCID. Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626 [TBL] [Abstract][Full Text] [Related]
9. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Mostoslavsky G; Fabian AJ; Rooney S; Alt FW; Mulligan RC Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16406-11. PubMed ID: 17062750 [TBL] [Abstract][Full Text] [Related]
10. Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do? Cowan MJ; Gennery AR J Allergy Clin Immunol; 2015 Nov; 136(5):1178-85. PubMed ID: 26055221 [TBL] [Abstract][Full Text] [Related]
11. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events. Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608 [TBL] [Abstract][Full Text] [Related]
12. Lymphopoiesis in transgenic mice over-expressing Artemis. Rivera-Munoz P; Abramowski V; Jacquot S; André P; Charrier S; Lipson-Ruffert K; Fischer A; Galy A; Cavazzana M; de Villartay JP Gene Ther; 2016 Feb; 23(2):176-86. PubMed ID: 26361272 [TBL] [Abstract][Full Text] [Related]
14. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome. van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo. Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454 [TBL] [Abstract][Full Text] [Related]
16. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Zhou S; Mody D; DeRavin SS; Hauer J; Lu T; Ma Z; Hacein-Bey Abina S; Gray JT; Greene MR; Cavazzana-Calvo M; Malech HL; Sorrentino BP Blood; 2010 Aug; 116(6):900-8. PubMed ID: 20457870 [TBL] [Abstract][Full Text] [Related]
17. Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide. Ijspeert H; Lankester AC; van den Berg JM; Wiegant W; van Zelm MC; Weemaes CM; Warris A; Pan-Hammarström Q; Pastink A; van Tol MJ; van Dongen JJ; van Gent DC; van der Burg M Genes Immun; 2011 Sep; 12(6):434-44. PubMed ID: 21390052 [TBL] [Abstract][Full Text] [Related]
18. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model. Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919 [TBL] [Abstract][Full Text] [Related]
19. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Moshous D; Callebaut I; de Chasseval R; Corneo B; Cavazzana-Calvo M; Le Deist F; Tezcan I; Sanal O; Bertrand Y; Philippe N; Fischer A; de Villartay JP Cell; 2001 Apr; 105(2):177-86. PubMed ID: 11336668 [TBL] [Abstract][Full Text] [Related]
20. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]